Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 29(1): 35-8, 2004 Feb.
Article in Chinese | MEDLINE | ID: mdl-16137001

ABSTRACT

OBJECTIVE: To observe the effects of Pinggan Xifeng decoction (PGXFD) on the change of mitochondrial membrane potential (MMP) after intracerebral hemorrhage (ICH) injury in rat brain and to explore the mechanism of PGXF decoction in the treatment of ICH. METHODS: VII type collagenase was stereotaxically injected into the globas pallidus of rats and spectrofluorometer was used to detect the fluorescence value of mitochondrial suspension. The neurobehavioral scores were used to evaluate the neurological defect. RESULTS: Neurological function defects were seen after ICH in rats and PGXFD decreased the neurological grades. The MMP of rats with ICH was reduced significantly 4 hours after the operation, peaking at 1 d and was higher at 3 d and 7 d than that of the sham group . MMP in the PGXFD group was obviously higher than that in the control group at 1 d, 3 d, and 7 d. CONCLUSION: MMP decreased in rats suffering from ICH. PGXFD can markedly depress the decreation of MMP.


Subject(s)
Cerebral Hemorrhage/drug therapy , Drugs, Chinese Herbal/pharmacology , Hippocampus/physiopathology , Mitochondria/physiology , Animals , Cerebral Hemorrhage/metabolism , Cerebral Hemorrhage/physiopathology , Drugs, Chinese Herbal/therapeutic use , Female , Hippocampus/metabolism , Male , Membrane Potentials , Random Allocation , Rats , Rats, Sprague-Dawley
2.
Hunan Yi Ke Da Xue Xue Bao ; 27(6): 491-4, 2002 Dec 28.
Article in Chinese | MEDLINE | ID: mdl-12658918

ABSTRACT

OBJECTIVE: To observe the effect of bizhongxiao (BZX) decoction on the expression of VEGF in the synovial membrane of C II-induced arthritis(CIA) in rats and to explore the mechanism of BZX decoction in the treatment of rheumatoid arthritis RA. METHODS: Seventy-five SD rats were randomly divided into four groups. The rat experimental arthritis model was established by subcutaneous injection of II collogen. The expression of VEGF was detected with immunohistochemistry in different times. RESULTS: The incidence of arthritis in the rats immunized with C II was approximately 88.57%. The arthritis index of the model group was rising, but that of the BZX decoction group and the methotrexate (MTX) group were decreasing on the 30th day. No expression of VEGF was found in the synovial membrane of the normal group. The expression of VEGF of the model group was notably higher than that of the BZX decoction group and the MTX group in different times (P < 0.01). The expression of VEGF of the model group rose step by step, but that of the BZX decoction group and the MTX group decreased and was significantly lower than that of the model group (P < 0.01). The expression of VEGF of the BZX decoction group was significantly lower than that of the MTX group(P < 0.05). CONCLUSION: The expression of VEGF is relative to the synovial pannus formation in RA. BZX decoction and MTX could decrease the expression of VEGF, but the curative effect of BZX decoction is significantly better than that of MTX. BZX decoction could inhibit the formation of the synovial pannus or bone in RA by decreasing the expression of VEGF.


Subject(s)
Arthritis, Rheumatoid/metabolism , Drugs, Chinese Herbal/pharmacology , Endothelial Growth Factors/biosynthesis , Intercellular Signaling Peptides and Proteins/biosynthesis , Lymphokines/biosynthesis , Phytotherapy , Synovial Membrane/metabolism , Animals , Arthritis, Rheumatoid/chemically induced , Arthritis, Rheumatoid/drug therapy , Collagen Type II , Endothelial Growth Factors/genetics , Female , Immunosuppressive Agents/pharmacology , Intercellular Signaling Peptides and Proteins/genetics , Lymphokines/genetics , Male , Methotrexate/pharmacology , Random Allocation , Rats , Rats, Sprague-Dawley , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
SELECTION OF CITATIONS
SEARCH DETAIL